Back to results
US 2009/0263320 A1Published application
Peptide-Based Compounds
AssigneeGe Healthcare Limited
InventorAlan Cuthbertson
Life of this patent
Estimating the term…
Abstract
The invention relates to new peptide-based compounds for use as diagnostic imaging agents or as therapeutic agents wherein the agents comprise targeting vectors which bind to integrin receptors.
Claims30
A compound of general formula (I)
- and pharmaceutically acceptable salt thereof
- wherein
- G represents glycine
- D represents aspartic acid
- Ra represents —(CH2)n— or —(CH2)n—C6H4— wherein
- n represents a positive integer 1 to 10
- h represents a positive integer 1 or 2
- X1 represents an amino acid residue wherein said amino acid possesses a functional side-chain such as an acid or amine,
- X2 and X6 represent independently amino acid residues together forming a disulphide bond,
- X3 represents arginine, N-methylarginine or an arginine mimetic,
- X4 represents a thiol-containing amino acid residue, and
- X5 represents a hydrophobic amino acid or derivatives thereof, and
- X7 represents a biomodifier moiety or is absent
- at least one of Z1 or Z2 is present and represents an antineoplastic agent, or an imageable moiety and
- W1 represents a spacer moiety or is absent
12 more elements
A pharmaceutical composition comprising an effective amount of a compound of general formula (I) or a salt thereof, together with one or more pharmaceutically acceptable adjuvants, excipients or diluents for use in enhancing image contrast in in vivo imaging or for treatment of a disease.
Dependencies are inferred from the claim text.